Replies to post #43974 on OncoSec Medical Inc (ONCSQ)

[chickpea598]

The Research Reception sunday at AACR has alot to look forward to. Price monday morning will hopefully reflect this.

The OncoSec Research Reception will feature the following presentations:

OMS-140 Protocol; Review of Intratumoral IL-12 Data in TNBC Presented at AACR
Pamela Munster, MD, UCSF Helen Diller Family Comprehensive Cancer Center
OMS-141 Protocol; Upcoming PD-1 Combination Clinical Trial in TNBC
Melinda Telli, MD, Stanford University Medical Center
Melanoma Data Update: OMS-100 & OMS-102 Combination Study
Alain Algazi, MD, UCSF Helen Diller Family Comprehensive Cancer Center
PISCES/KEYNOTE-695 Operational Update
Sharron Gargosky, PhD, Chief Clinical and Regulatory Officer, OncoSec

[dr_lowenstein]

when the price declines it is obvious manipulation, when it goes up, it is admiration for the company, kinda strange LOL